Print Page

Products found to contain undeclared medicines

The United States: Recall: Ultra ZX LABS, L.L.C. issues voluntary nationwide recall of Ultra Zx since it contains undeclared sibutramine and phenolphthalein
UltraZx, Labs, L.L.C. is voluntarily recalling UltraZx weight loss supplements. This product has been found to contain undeclared sibutramine and phenolphthalein. FDA laboratory analysis of confirmed that UltraZx contains sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it presents a cancer causing risk. This product may also interact, in life-threating ways, with other medications a consumer may be taking. Ultra ZX LABS, L.L.C. has not received any reports of adverse events related to this recall.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Wednesday, March 11, 2015
Issued at HKT 16:00